Helms et al. suggested that TOB1 phosphorylation prevents the anti-proliferative role of TOB1 in HER2 and/or EGFR-positive breast cancers, implying that phosphorylated TOB1 is an inactive form [32]. This evidence concerns the gene TOB1 and breast carcinoma.